SEARCH

SEARCH BY CITATION

References

  • Anderson, D.M., Maraskovsky, E., Billingsley, W.L., Dougall, W.C., Tometsko, M.E., Roux, E.R., Teepe, M.C., DuBose, R.F., Cosman, D. & Galibert, L. (1997) A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature, 390, 175179.
  • Armitage, P. & Berry, G. (1994) Statistical Inference. Blackwall Science Ltd, Oxford.
  • Bord, S., Vedi, S., Beavan, S.R., Horner, A. & Compston, J.E. (2000) Megakaryocyte population in human bone marrow increases with estrogen treatment: a role in bone remodeling? Bone, 27, 397401.
  • Bord, S., Beavan, S., Ireland, D., Horner, A. & Compston, J.E. (2001) Mechanisms by which high-dose estrogen therapy produces anabolic skeletal effects in postmenopausal women: role of locally produced growth factors. Bone, 29, 216222.
  • Bord, S., Frith, E., Ireland, D.C., Scott, M.A., Craig, J.I.O. & Compston, J.E. (2002) Estrogen stimulates megakaryocyte differentiation and estrogen receptor protein and mRNA expression. Journal of Bone and Mineral Research, 17, OC2.
  • Bord, S., Frith, E., Ireland, D.C., Scott, M.A., Craig, J.I.O. & Compston, J.E. (2004) Estrogen stimulates differentiation of megakaryocytes and modulates their expression of estrogen receptors a and b. Journal of Cellular Biochemistry, 92, 249257.
  • Braidman, I.P., Hainey, L., Batra, G., Selby, P.L., Saunders, P.T.K. & Hoyland, J.A. (2001) Localization of estrogen receptor beta protein expression in adult human bone. Journal of Bone and Mineral Research, 16, 214220.
  • Brzozowski, A.M., Pike, A.C.W., Dauter, Z., Hubbard, R.E., Bonn, T., Engstrom, O., Ohman, L., Greene, G.L., Gustafsson, J.A. & Carlquist, M. (1997) Molecular basis of agonism and antagonism in the oestrogen receptor. Nature, 389, 753758.
  • Bucay, N., Sarosi, I., Dunstan, C.R., Morony, S., Tarpley, J., Capparelli, C., Scully, S., Tan, H.L., Xu, W.L., Lacey, D.L., Boyle, W.J. & Simonet, W.S. (1998) Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes & Development, 12, 12601268.
  • Chagraoui, H., Sabri, S., Capron, C., Villeval, J.-L., Vainchenker, W. & Wendling, F. (2003) Expression of osteoprotegerin mRNA and protein in murine megakaryocytes. Experimental Hematology, 31, 10811088.
  • Chow, J., Tobias, J.H., Colston, K.W. & Chambers, T.J. (1992) Estrogen maintains trabecular bone volume in rats not only by suppression of bone resorption but also by stimulation of bone formation. Journal of Clinical Investigation, 89, 7478.
  • Compston, J.E. (2002) Bone marrow and bone: a functional unit. Journal of Endocrinology, 173, 387394.
  • Croucher, P.I., Shipman, C.M., Lippitt, J., Perry, M., Asosingh, K., Hijzen, A., Brabbs, A.C., van Beek, E.J.R., Holen, I., Skerry, T.M., Dunstan, C.R., Russell, G.R., Van Camp, B. & Vanderkerken, K. (2001) Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma. Blood, 98, 35343540.
  • Edwards, M.W., Bain, S.D., Bailey, M.C., Lantry, M.M. & Howard, G.A. (1992) 17-beta-estradiol stimulation of endosteal bone-formation in the ovariectomized mouse – an animal-model for the evaluation of bone-targeted estrogens. Bone, 13, 2934.
  • Ellis, M.H., Avraham, H. & Groopman, J.E. (1995) The regulation of megakaryocytopoiesis. Blood Reviews, 9, 16.
  • Fink, L., Seeger, W., Ermert, L., Hanze, J., Stahl, U., Grimminger, F., Kummer, W. & Bohle, R.M. (1998) Real-time quantitative RT-PCR after laser-assisted cell picking. Nature Medicine, 4, 13291333.
  • Fuller, K., Owens, J.M. & Chambers, T.J. (1998) Induction of osteoclast formation by parathyroid hormone depends on an action on stromal cells. Journal of Endocrinology, 158, 341350.
  • Genever, P.G., Wilkinson, D.J.P., Patton, A.J., Peet, N.M., Hong, Y., Mathur, A., Erusalimsky, J.D. & Skerry, T.M. (1999) Expression of a functional N-methyl-D-aspartate-type glutamate receptor by bone marrow megakaryocytes. Blood, 93, 28762883.
  • Harris, S.A., Tau, K.R., Turner, R.T. & Spelsberg, T.C. (1996) Estrogens and progestins. In: Principles in Bone Biology (ed. by J.P.Bilezikian, L.G.Raisz & G.A.Rodan), pp. 507520. Academic Press, New York.
  • Hoffman, R., Straneva, J., Yang, H.H., Bruno, E. & Brandt, J. (1987) New insights into the regulation of human megakaryocytopoiesis. Blood Cells, 13, 7586.
  • House, M.G., Kohlmeier, L., Chattopadhyay, N., Kifor, O., Yamaguchi, T., Leboff, M.S., Glowacki, J. & Brown, E.M. (1997) Expression of an extracellular calcium-sensing receptor in human and mouse bone marrow cells. Journal of Bone and Mineral Research, 12, 19591970.
  • Ireland, D.C., Bord, S., Beavan, S.R. & Compston, J.E. (2002) Effects of estrogen on collagen synthesis by cultured human osteoblasts depend on the rate of cellular differentiation. Journal of Cellular Biochemistry, 86, 251257.
  • Kartsogiannis, V., Zhou, H., Horwood, N.J., Thomas, R.J., Hards, D.K., Quinn, J.M.W., Niforas, P., Ng, K.W., Martin, T.J. & Gillespie, M.T. (1999) Localization of RANKL (Receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeletal tissues. Bone, 25, 525534.
  • Kelm, R.J., Hair, G.A., Mann, K.G. & Grant, B.W. (1992) Characterization of human osteoblast and megakaryocyte-derived osteonectin (Sparc). Blood, 80, 31123119.
  • Kong, Y.Y., Yoshida, H., Sarosi, I., Tan, H.L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A.J., Van, G., Itie, A., Khoo, W., Wakeham, A., Dunstan, C.R., Lacey, D.L., Mak, T.W., Boyle, W.J. & Penninger, J.M. (1999) OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature, 397, 315323.
  • Landshman, N. & Bleiberg, I. (1979) Effect of estradiol on erythropoiesis and megakaryocytopoiesis in mice. Israel Journal of Medical Science, 15, 140146.
  • Li, J., Sarosi, I., Yan, X.-Q., Morony, S., Capparelli, C., Tan, H.-L., McCabe, S., Elliott, R., Scully, S., Van, G., Kaufman, S., Juan, S.-C., Sun, Y., Tarpley, J., Martin, L., Christensen, K., McCabe, J., Kostenuik, P., Hsu, H., Fletcher, F., Dunstan, C.R., Lacey, D.L. & Boyle, W.J. (2000) RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. PNAS, 97, 15661571.
  • Pearse, R.N., Sordillo, E.M., Yaccoby, S., Wong, B.R., Liau, D.F., Colman, N., Michaeli, J., Epstein, J. & Choi, Y. (2001) Multiple myeloma disrupts the TRANCE/osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression. Proceedings of the National Academy of Sciences of the United States of America, 98, 1158111586.
  • Perry, M.J., Samuels, A., Bird, D. & Tobias, J.H. (2000) Effects of high-dose estrogen on murine hematopoietic bone marrow precede those on osteogenesis. American Journal of Physiology-Endocrinology and Metabolism, 279, E1159E1165.
  • Samuels, A., Perry, M.J. & Tobias, J.H. (1998) Analysis of the relationship between oestrogen induced osteosclerosis and changes in megakaryocyte populations in female mice. Journal of Bone and Mineral Research, 13, O16.
  • Samuels, A., Perry, M.J. & Tobias, J.H. (1999) High-dose estrogen-induced osteogenesis in the mouse is partially suppressed by indomethacin. Bone, 25, 675680.
  • Simonet, W.S., Lacey, D.L., Dunstan, C.R., Kelley, M., Chang, M.S., Luthy, R., Nguyen, H.Q., Wooden, S., Bennett, L., Boone, T., Shimamoto, G., DeRose, M., Elliott, R., Colombero, A., Tan, H.L., Trail, G., Sullivan, J., Davy, E., Bucay, N., RenshawGegg, L., Hughes, T.M., Hill, D., Pattison, W., Campbell, P., Sander, S., Van, G., Tarpley, J., Derby, P., Lee, R. & Boyle, W.J. (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell, 89, 309319.
  • Tarantino, M.D., Kunicki, T.J. & Nugent, D.J. (1994) The estrogen-receptor is present in human megakaryocytes. Annals of the New York Academy of Sciences, 714, 293296.
  • Thiede, M.A., Smock, S.L., Petersen, D.N., Grasser, W.A., Thompson, D.D. & Nishimoto, S.K. (1994) Presence of messenger-ribonucleic-acid encoding osteocalcin, a marker of bone turnover, in bone-marrow megakaryocytes and peripheral-blood platelets. Endocrinology, 135, 929937.
  • Tsai, M.-J., Clark, J.H., Schrader, W.T. & O'Malley, B.W. (1998) Mechanisms of action of hormones that act as transcription factors. In: Textbook of Endocrinolgy (ed. by J.D.Wilson, D.W.Foster, H.M.Kronenburg & P.R.Larsen), pp. 5594. Saunders WB, Philadelphia.
  • Tsuda, E., Goto, M., Mochizuki, S., Yano, K., Kobayashi, F., Morinaga, T. & Higashio, K. (1997) Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochemical and Biophysical Research Communications, 234, 137142.
  • Turner, R.T., Riggs, B.L. & Spelsberg, T.C. (1994) Skeletal effects of estrogen. Endocrine Reviews, 15, 275300.
  • Vedi, S. & Compston, J.E. (1996) The effects of long-term hormone replacement therapy on bone remodeling in postmenopausal women. Bone, 19, 535539.
  • Vedi, S., Purdie, D.W., Ballard, P., Bord, S., Cooper, A.C. & Compston, J.E. (1999) Bone remodeling and structure in postmenopausal women treated with long-term, high-dose estrogen therapy. Osteoporosis International, 10, 5258.
  • Wahab, M., Ballard, P., Purdie, D.W., Cooper, A. & Willson, J.C. (1997) The effect of long term oestradiol implantation on bone mineral density in postmenopausal women who have undergone hysterectomy and bilateral oophorectomy. British Journal of Obstetrics and Gynaecology, 104, 728731.